Search - tctmd.com

Displaying 101 - 120 of 299

Sort: Relevancy | Date

Presentation THT 2023

Socioeconomic Effectors of Kansas City Cardiomyopathy Questionnaire Self-Efficacy

Presenter: Lawrence Zeldin

March 21, 2023

Presentation THT 2023

Outcomes of Takotsubo Cardiomyopathy in Octogenarians, Nonagenarians and Centenarians: A population-based study

Presenter: Rafail Beshai

March 21, 2023

Presentation THT 2023

Left ventricular reconstruction compared to optimal medical therapy in patients with ischemic cardiomyopathy

Presenter: Oleg Polonetsky

March 21, 2023

Presentation THT 2023

Early Clinical Outcomes of Patients Receiving Intraaortic Balloon Pump Versus Micro Axial flow pump in Patients with Takotsubo Cardiomyopathy: Analysis from Nationwide Readmissions Database

Presenter: Sun-Joo Jang

March 21, 2023

Presentation THT 2023

Applications of Gene Therapy in Cardiomyopathies (TBD)

Presenter: Eric Adler

March 20, 2023

Presentation THT 2023

Emerging Medical Pathways for Heart Failure Therapies

Presenter: Steven Marx

March 20, 2023

Presentation THT 2023

The Role of Monitoring Devices in Optimizing Medical Therapies

Presenter: Anu Lala-Trindade

March 20, 2023

Presentation THT 2023

Beyond the Four Foundational Therapies: Vericiguat and Omecamtiv Mecarbil

Presenter: John Teerlink

March 20, 2023

Presentation THT 2023

The Foundation of Foundational Therapies for Heart Failure

Presenter: Biykem Bozkurt

March 20, 2023

Presentation THT 2023

Results of endovascular and surgical treatment of functional mitral insufficiency in patients with cardiomyopathy

Presenter: Alena Kurlianskaya

March 20, 2023

Presentation TCT 2022

TCT 681: Alcohol Septal Ablation for Preoperative Optimization Prior to Noncardiac Surgery in Hypertrophic Cardiomyopathy

Presenter: Sina Salehi Omran

September 18, 2022

Presentation TCT 2022

TCT 348: Evaluating improvement in regional left ventricular function after hybrid minimally invasive left ventricular reconstruction in ischemic cardiomyopathy: CT- or MRI-based inward displacement to overcome current shortcomings in imaging

Presenter: Romy Hegeman

September 18, 2022

Presentation TCT 2022

TCT 346: Safety of right and left ventricular endomyocardial biopsy in Heart Transplant and Cardiomyopathy patients

Presenter: Konstantinos Bermpeis

September 18, 2022

Presentation TCT 2022

TCT 345: Right ventricular failure in patients presenting with Takotsubo Cardiomyopathy

Presenter: Suchith Shetty

September 18, 2022

Presentation TVT 2022

Percutaneous Intramyocardial Septal Radiofrequency Ablation (PIMSRA) for Hypertrophic Obstructive Cardiomyopathy: Results From the First 200 Patients

Presenter: David Hsi

June 09, 2022

Presentation ACC 2022

Updated Cumulative Results Of Treatment With Mavacamten From The EXPLORER-LTE Cohort Of The MAVA-LTE Study In Patients With Obstructive Hypertrophic Cardiomyopathy

Presenter: Florian Rader

April 04, 2022

Presentation ACC 2022

Myosin Inhibition to Defer Surgical Myectomy or Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy

Presenter: Milind Y Desai

April 03, 2022

Presentation THT 2022

Transthyretin Amyloid Cardiomyopathy (ATTR-CM): Evaluating clinical findings to support earlier diagnosis and management

Presenter: Gregg Lanier

February 01, 2022

Presentation TVT 2021

Hypertrophic Obstructive Cardiomyopathy

Presenter: Paul Sorajja

July 20, 2021

Advertisement

Socioeconomic Effectors of Kansas City Cardiomyopathy Questionnaire Self-Efficacy

Outcomes of Takotsubo Cardiomyopathy in Octogenarians, Nonagenarians and Centenarians: A population-based study

Left ventricular reconstruction compared to optimal medical therapy in patients with ischemic cardiomyopathy

Early Clinical Outcomes of Patients Receiving Intraaortic Balloon Pump Versus Micro Axial flow pump in Patients with Takotsubo Cardiomyopathy: Analysis from Nationwide Readmissions Database

Applications of Gene Therapy in Cardiomyopathies (TBD)

Emerging Medical Pathways for Heart Failure Therapies

The Role of Monitoring Devices in Optimizing Medical Therapies

Beyond the Four Foundational Therapies: Vericiguat and Omecamtiv Mecarbil

The Foundation of Foundational Therapies for Heart Failure

Results of endovascular and surgical treatment of functional mitral insufficiency in patients with cardiomyopathy

TCT 681: Alcohol Septal Ablation for Preoperative Optimization Prior to Noncardiac Surgery in Hypertrophic Cardiomyopathy

TCT 348: Evaluating improvement in regional left ventricular function after hybrid minimally invasive left ventricular reconstruction in ischemic cardiomyopathy: CT- or MRI-based inward displacement to overcome current shortcomings in imaging

TCT 346: Safety of right and left ventricular endomyocardial biopsy in Heart Transplant and Cardiomyopathy patients

TCT 345: Right ventricular failure in patients presenting with Takotsubo Cardiomyopathy

Percutaneous Intramyocardial Septal Radiofrequency Ablation (PIMSRA) for Hypertrophic Obstructive Cardiomyopathy: Results From the First 200 Patients

Updated Cumulative Results Of Treatment With Mavacamten From The EXPLORER-LTE Cohort Of The MAVA-LTE Study In Patients With Obstructive Hypertrophic Cardiomyopathy

Myosin Inhibition to Defer Surgical Myectomy or Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy

Transthyretin Amyloid Cardiomyopathy (ATTR-CM): Evaluating clinical findings to support earlier diagnosis and management

Hypertrophic Obstructive Cardiomyopathy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content